Cite
HARVARD Citation
Ribero, S. et al. (2019). BRAFi/MEKi in patients with metastatic melanoma: predictive factors of complete response. Future oncology. pp. 133-139. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ribero, S. et al. (2019). BRAFi/MEKi in patients with metastatic melanoma: predictive factors of complete response. Future oncology. pp. 133-139. [Online].